Clinical practice guidelines for rituximab treatment in children with steroid-sensitive nephrotic syndrome
Authors:
Open Access
- 13 August 2025
- journal article
- review article
- Published by Springer Nature in World Journal of Pediatrics
- Vol. 21 (8) , 775-791
Abstract
Background: Steroid-sensitive nephrotic syndrome is a prevalent glomerular disease in children. The 2021 guidelines for glomerular disease management by Kidney Disease: Improving Global Outcomes and the 2023 recommendations for steroid-sensitive nephrotic syndrome management by International Pediatric Nephrology Association recommend rituximab for frequently relapsing nephrotic syndrome and steroid-dependent nephrotic syndrome in children. However, there is considerable variation in rituximab application, including administration timing, dose, frequency, concomitant medications, and follow-up schedules. In addition, rituximab use for nephrotic syndrome remains off-label in most countries. Data sources: The “Pediatric Nephrology Committee of the Chinese Medical Doctor Association”, the “Pediatric Nephrology Society of the Chinese Medical Association”, and the “Fudan University GRADE Center” collaborated to develop a clinical practice guideline for rituximab in pediatric steroid-sensitive nephrotic syndrome. Databases and starting/ending time for retrieval were as follows. Databases in English: PubMed, Embase, Cochrane, and Scopus; database in Chinese: Chinese Biomedical Literature Service provided by SinoMed. The publication dates were limited to those from 2004 to June 26, 2022. Results: Through systematic reviews and meta-analyses covering nine clinically relevant patient or population covered, intervention, comparator, and outcome questions, seven recommendations were formulated and formally graded according to these guidelines. Conclusions: This guideline aspires to serve as a pivotal resource for healthcare providers, offering guidance on administration timing, dosage, frequency, concomitant medications, and follow-up protocols.Keywords
This publication has 69 references indexed in Scilit:
- GRADE guidelines: A new series of articles in the Journal of Clinical EpidemiologyJournal of Clinical Epidemiology, 2011
- GRADE guidelines: 1. Introduction—GRADE evidence profiles and summary of findings tablesJournal of Clinical Epidemiology, 2011
- Rituximab efficiency in children with steroid-dependent nephrotic syndromePediatric Nephrology, 2010
- Single infusion of rituximab for persistent steroid-dependent minimal-change nephrotic syndrome after long-term cyclosporinePediatric Nephrology, 2010
- Rituximab in refractory nephrotic syndromePediatric Nephrology, 2009
- Single dose of rituximab for refractory steroid-dependent nephrotic syndrome in childrenPediatric Nephrology, 2009
- Rituximab treatment for severe steroid- or cyclosporine-dependent nephrotic syndrome: a multicentric series of 22 casesPediatric Nephrology, 2008
- Assessment and clinical interpretation of reduced IgG valuesAnnals of Allergy, Asthma & Immunology, 2007
- Change of the course of steroid-dependent nephrotic syndrome after rituximab therapyPediatric Nephrology, 2004
- Reference intervals for serum IgG, IgA, IgM, C3, and C4 as determined by rate nephelometry.Clinical Chemistry, 1982